Abstract
Aims
Few studies have assessed the prevalence of diabetes and hypertension among pregnant women in China after the implementation of universal two-child policy. Therefore, the aim of the study was to determine the prevalence of diabetes and hypertension from 2016 to 2018 among pregnant women in Jiangsu, China, after the policy implementation.
Methods
We analysed data from pregnant women who delivered their neonates between 2016 and 2018 in the Northern Jiangsu People’s Hospital. All pregnant women irrespective of their gestation weeks underwent oral glucose intolerance tests in a fasting state.
Results
A total of 3262 pregnant women were included. The overall prevalence of diabetes and hypertension in pregnant women was 21.8% and 2.4%, respectively. In addition, the prevalence of low birth weight (LBW) and macrosomia for participants with diabetes was significantly higher than those without diabetes (LBW: 4.4. vs. 2.6%, p = 0.017; macrosomia: 10.1 vs. 5.8%, p < 0.001). There was a significant increasing trend in the prevalence of diabetes, which was from 18.9% in 2016 to 25.4% in 2018 (p < 0.001). Similarly, there was also a significant increasing trend in the prevalence of diabetes across the increasing age group (from 16.4% in 18–24 years to 47.6% in 40–45 years) (p < 0.001).
Conclusion
Our study reported a high prevalence of diabetes among this sample of Chinese pregnant women. In addition, advanced maternal age was found to be a risk factor of diabetes in pregnant women. Therefore, in view of high prevalence of diabetes, screening for diabetes in pregnant women is strongly recommended, regardless of their age, BMI, and gestation weeks.
Similar content being viewed by others
References
Zheng Y, Ley SH, Hu FB. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat Rev Endocrinol. 2018;14:88–98. https://doi.org/10.1038/nrendo.2017.151.
American Diabetes Association. Management of diabetes in pregnancy: standards of medical care in diabetes—2019. Diabetes Care. 2019;42:S165–S72. https://doi.org/10.2337/dc19-S014.
Ji J, He Z, Yang Z, Mi Y, Guo N, Zhao H, et al. Comparing the efficacy and safety of insulin detemir versus neutral protamine Hagedorn insulin in treatment of diabetes during pregnancy: a randomized, controlled study. BMJ Open Diabetes Res Care. 2020;8:e001155. https://doi.org/10.1136/bmjdrc-2019-001155.
Tranquilli AL. Hypertension during pregnancy is associated with increased risk of later cardiovascular disease, kidney disease and diabetes. Evid Based Nurs. 2014;17:36–7. https://doi.org/10.1136/eb-2013-101322.
Li H-t, Xue M, Hellerstein S, Cai Y, Gao Y, Zhang Y, et al. Association of China’s universal two child policy with changes in births and birth related health factors: national, descriptive comparative study. BMJ. 2019;366:l4680. https://doi.org/10.1136/bmj.l4680.
Makgoba M, Savvidou MD, Steer PJ. An analysis of the interrelationship between maternal age, body mass index and racial origin in the development of gestational diabetes mellitus. BJOG. 2012;119:276–82. https://doi.org/10.1111/j.1471-0528.2011.03156.x.
Zhou H, Lu Y, Pan B, Zhao Q, Ma ZF. Iodine deficiency as assessed by neonatal TSH in a sample of mother-and-newborn pairs in Jiangsu Province, China. Biol Trace Elem Res. 2020. https://doi.org/10.1007/s12011-020-02135-6.
Mak JKL, Lee AH, Pham NM, Pan XF, Tang L, Binns CW, et al. Gestational diabetes incidence and delivery outcomes in Western China: a prospective cohort study. Birth. 2019;46:166–72. https://doi.org/10.1111/birt.12397.
Moser M, Brown CM, Rose CH, Garovic VD. Hypertension in pregnancy: is it time for a new approach to treatment? J Hypertens. 2012;30:1092–100. https://doi.org/10.1097/HJH.0b013e3283536319.
WHO. International statistical classification of diseases and related health problems. Geneva: WHO; 2004.
Ye J, Torloni MR, Ota E, Jayaratne K, Pileggi-Castro C, Ortiz-Panozo E, et al. Searching for the definition of macrosomia through an outcome-based approach in low- and middle-income countries: a secondary analysis of the WHO Global Survey in Africa, Asia and Latin America. BMC Pregnancy Childbirth. 2015;15:324. https://doi.org/10.1186/s12884-015-0765-z.
WHO Reproductive Health Library. WHO recommendation on the diagnosis of gestational diabetes in pregnancy. Geneva: WHO; 2016.
Meyer WJ, Carbone J, Gauthier DW, Gottmann DA. Early gestational glucose screening and gestational diabetes. J Reprod Med. 1996;41:675–9.
Seshiah V, Balaji V, Balaji MS, Paneerselvam A, Arthi T, Thamizharasi M, et al. Gestational diabetes mellitus manifests in all trimesters of pregnancy. Diabetes Res Clin Pract. 2007;77:482–4. https://doi.org/10.1016/j.diabres.2007.01.001.
Gao C, Sun X, Lu L, Liu F, Yuan J. Prevalence of gestational diabetes mellitus in mainland China: a systematic review and meta-analysis. J Diabetes Investig. 2019;10:154–62. https://doi.org/10.1111/jdi.12854.
Gao WG, Dong YH, Pang ZC, Nan HR, Zhang L, Wang SJ, et al. Increasing trend in the prevalence of type 2 diabetes and pre-diabetes in the Chinese rural and urban population in Qingdao, China. Diabet Med. 2009;26:1220–7. https://doi.org/10.1111/j.1464-5491.2009.02832.x.
Zhang F, Dong L, Zhang C, Li B, Wen J, Gao W, et al. Increasing prevalence of gestational diabetes mellitus in Chinese women from 1999 to 2008. Diabet Med. 2011;28:652–7.
Hu C, Jia W. Diabetes in China: epidemiology and genetic risk factors and their clinical utility in personalized medication. Diabetes. 2018;67:3–11. https://doi.org/10.2337/dbi17-0013.
Eades CE, Cameron DM, Evans JMM. Prevalence of gestational diabetes mellitus in Europe: a meta-analysis. Diabetes Res Clin Pract. 2017;129:173–81. https://doi.org/10.1016/j.diabres.2017.03.030.
Casagrande SS, Linder B, Cowie CC. Prevalence of gestational diabetes and subsequent type 2 diabetes among U.S. women. Diabetes Res Clin Pract. 2018;141:200–8. https://doi.org/10.1016/j.diabres.2018.05.010.
Nguyen CL, Pham NM, Binns CW, Duong DV, Lee AH. Prevalence of gestational diabetes mellitus in eastern and southeastern Asia: a systematic review and meta-analysis. J Diabetes Res. 2018;2018:1–10.
Sami W, Ansari T, Butt NS, Hamid MRA. Effect of diet on type 2 diabetes mellitus: a review. Int J Health Sci. 2017;11:65–71.
Kampmann U, Madsen LR, Skajaa GO, Iversen DS, Moeller N, Ovesen P. Gestational diabetes: a clinical update. World J Diabetes. 2015;6:1065–72. https://doi.org/10.4239/wjd.v6.i8.1065.
Bao W, Tobias DK, Bowers K, Chavarro J, Vaag A, Grunnet LG, et al. Physical activity and sedentary behaviors associated with risk of progression from gestational diabetes mellitus to type 2 diabetes mellitus: a prospective cohort study. JAMA Intern Med. 2014;174:1047–55. https://doi.org/10.1001/jamainternmed.2014.1795.
Miao M, Dai M, Zhang Y, Sun F, Guo X, Sun G. Influence of maternal overweight, obesity and gestational weight gain on the perinatal outcomes in women with gestational diabetes mellitus. Sci Rep. 2017;7:305. https://doi.org/10.1038/s41598-017-00441-z.
Chen Y, Peng Q, Yang Y, Zheng S, Wang Y, Lu W. The prevalence and increasing trends of overweight, general obesity, and abdominal obesity among Chinese adults: a repeated cross-sectional study. BMC Public Health. 2019;19:1293. https://doi.org/10.1186/s12889-019-7633-0.
Solomon CG, Willett WC, Carey VJ, Rich-Edwards J, Hunter DJ, Colditz GA, et al. A prospective study of pregravid determinants of gestational diabetes mellitus. JAMA. 1997;278:1078–83.
Metzger BE, Gabbe SG, Persson B, Buchanan TA, Catalano PA, Damm P, et al. International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care. 2010;33:676–82. https://doi.org/10.2337/dc09-1848.
Ornoy A. Prenatal origin of obesity and their complications: gestational diabetes, maternal overweight and the paradoxical effects of fetal growth restriction and macrosomia. Reprod Toxicol. 2011;32:205–12. https://doi.org/10.1016/j.reprotox.2011.05.002.
Parikh RM, Joshi SR, Menon PS, Shah NS. Intensive glycemic control in diabetic pregnancy with intrauterine growth restriction is detrimental to fetus. Med Hypotheses. 2007;69:203–5. https://doi.org/10.1016/j.mehy.2006.10.020.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
The study was approved by the Ethics Committee of the Northern Jiangsu People’s Hospital (reference no. 2018063).
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed consent
Informed consent was obtained from all individual participants included in the study. No animals were used in this study.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Ma, Z.F., Zhou, H., Ma, J. et al. Prevalence of diabetes mellitus and hypertension during pregnancy in eastern China after the implementation of universal two-child policy. Int J Diabetes Dev Ctries 41, 221–227 (2021). https://doi.org/10.1007/s13410-020-00872-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13410-020-00872-x